Results 251 to 260 of about 7,636,605 (392)

Unlocking the potential: multimodal AI in biotechnology and digital medicine-economic impact and ethical challenges. [PDF]

NPJ Digit Med
Bhushan A, Misra P.
europepmc   +1 more source

Drug industry anxious about scrapping price regulation scheme [PDF]

, 2008
Andrew Cole
openalex   +1 more source

Systemic T Cell Receptor Profiling Reveals Adaptive Immune Activation and Potential Immune Signatures of Diagnosis and Brain Atrophy in Epilepsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Epilepsy is increasingly associated with immune dysregulation and inflammation. The T cell receptor (TCR), a key mediator of adaptive immunity, shows repertoire alterations in various immune‐mediated diseases. The unique TCR sequence serves as a molecular barcode for T cells, and clonal expansion accompanied by reduced overall TCR ...
Yong‐Won Shin, Sang Bin Hong, Yong Woo Shin, Inpyeong Hwang, Jaeseong Oh, Jihyeon Choi, Narae Kim, Jangsup Moon, Keun‐Hwa Jung, Kyung‐Il Park, Ki‐Young Jung, Kon Chu, Sang Kun Lee   +12 more
wiley   +1 more source

Industry payments to US neurologists related to multiple sclerosis drugs and prescribing (2015-2019): a retrospective cohort study. [PDF]

BMJ Open
Sayed A, Gupta R, Ramachandran R, Rivero-de-Aguilar A, Ross JS.   +4 more
europepmc   +1 more source

Egyptian Herbal Drug Industry: Challenges and Future Prospects

, 2011
N. Abdel-Azim, A. Shams, A. Shahat, M. M. E. Missi, I. Ismail, M. Hammouda   +5 more
semanticscholar   +1 more source

Defining Molecular Targets for Drug Design: Synergism Between Academia and Industry

, 2005
Andrew C. Chan
openalex   +1 more source

Drug industry weakens US bill about disclosure of gifts [PDF]

, 2008
Bob Burton
openalex   +1 more source

Annual 12‐Week Dosing Gap of Natalizumab: Clinical Efficacy, Blood Biomarkers, and CSF Cell Composition

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Natalizumab (NTZ) is a highly effective therapy for multiple sclerosis (MS); however, its use is limited by the risk of a rare potentially severe opportunistic brain infection, progressive multifocal leukoencephalopathy (PML). Alternative dosing strategies are evaluated to reduce PML risk while still maintaining efficacy, which ...
Regina Berkovich, Tilman Schneider‐Hohendorf, Eric Baetscher, Evan L. Riddle, Marie Deffner, Emily Katsnelson, Janine Ferrant‐Orgettas, Julie Czerkowicz, John Anderson, Susan E. Goelz, Nicholas Schwab   +10 more
wiley   +1 more source

Changes in the association between county industrial composition and working-age mortality from 2000 to 2022. [PDF]

SSM Popul Health
Zhang X, Gutin I, Monnat SM, Montez JK.
europepmc   +1 more source